chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had a stomach flu or virus that has past around the whole family; diarrhea; fever; This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever). At the time of the report, GASTROENTERITIS VIRAL (had a stomach flu or virus that has past around the whole family), DIARRHOEA (diarrhea) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.
Patient received first vaccination on 11/10/2009 and a second on 12/02/2009.
Too busy to receive 2nd dose on due date; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too busy to receive 2nd dose on due date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too busy to receive 2nd dose on due date). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too busy to receive 2nd dose on due date) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a nurse practitioner concerning a 14 year old female who on an unknown date was vaccinated with a dose of GARDASIL (Lot No. not provided). On 09-OCT-2009 the patient developed a breast lump after completing the GARDASIL series. The patient called the physician office. At the time of the report, the patient had not recovered. Additional information has been requested.
rash on arm; mucous in her throat; Teeth chattering; This is a spontaneous report from a non-contactable consumer (parent). A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, on Mar2021 (at the age of 16-year-old), at dose 1, single for covid-19 immunization. Medical history included allergies to tree nuts; had anaphylactic reactions to tree nuts. The patient's concomitant medications were not reported. The patient experienced rash on arm, mucous in her throat, and teeth chattering on Mar2021. Therapeutic measures were taken included Benadryl and she was fine. The outcome of the event was recovered on Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Info has been received from a health professional concerning a 31 year old, white female, CNA, with an allergy to erythromycin, who on 3/14/05 was vaccinated in the morning with a first SC dose, in the upper arm of varicella virus vaccine live. It was noted that there was no illness at the time of vaccination. On 3/30/05 (also report as 3/29/05), the pt developed a varicella-like rash of about 30 lesions and a low-grade fever. It was reported that the pt was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Follow-up info from a health professional indicated that the pt developed a low-grade fever on 3/29/05, at 15:00 PM, followed by an outbreak of vesicles, on the face, scalp and torso, on 3/30/05. It was reported that on 4/11/05, the pt recovered. Additional info is not expected.
All my joints hurt severely. It started after I received the vaccine and has progressively gotten worse. I keep waiting for it to get better, since I read that side effects can take up to two weeks to go away, but I feel worse today than ever. I have never had joint pain like this before. It's in every joint. My ankles swole up that same day and have still not gone down. My feet, ankles, and knees are the worst but I didn't start having extreme pain in my back, elbows, and hands until 5 days after the vaccine. It's as if it's rising. I also had a fever of 104 the night I received the vaccine. I read that is normal.   I do not have health insurance and can not afford to see a doctor. I have also felt very tired since receiving the vaccine. I am usually full of energy but can not get my energy back. I have been drinking plenty of water.
Some of the liquid came out as it was coming out of his arm; A spontaneous report was received from a consumer concerning a 76 year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some of the liquid came out as it was coming out of his arm (inappropriate dose of vaccine administration).   The patient's medical history was not provided. No Concomitant medication was reported .  On 03 Mar 2021 ,the patient received their first of two planned doses of mRNA-1273  intramuscularly for prophylaxis of COVID-19 infection Lot  030A21A. Patient reported that the vaccine liquid came out as it was coming out from his arm and also patient felt like the lady who administered the vaccine was incorrectly administered to the patient.  No treatment was taken for the events .  Action taken with mRNA-1273 in response to the events was unknown.  The outcomes of the events were considered, some of the liquid came out as it was coming out of his arm (inappropriate dose of vaccine administration) was considered as resolved on 03 Mar 2021.; Reporter's Comments: This report refers to a case of 76 year-old, male patient who experienced non-serious unexpected event of some of the liquid came out as it was coming out of his arm (Incomplete dose administered) for mRNA-1273, lot # 030A21A. There were no reported AEs associated with this case of Incomplete dose administered.
Information has been received from a registered nurse referring to an 8 year old female patient. On an unknown date, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (route, dose, strength were unknown). As an infant, she only received only one dose of the vaccine. Recently (date unknown), the patient developed what appeared to be a possible case of chicken pox. The outcome of the event was reported as not recovered/not resolved. The causality was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
ACUTE RESPIRATORY FAILURE 2/27/2022 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART
loss of use of left arm , emergency room vadnais heights, back pain ,chest pain radiating from back to front and down arm to elbow chest xray in er. followed by series of other dr app. still doing physical therapy unable to work, asm of need roto cuff on right arm which is why i opted to have shot in left arm, when man gave shot needle came out and he popped it back in with a flat hand, just didnt seem right , now i know why . thank you
Four days after being exposed I contracted COVID. I started to have a scratchy and horse throat. The next day I could hardly speak. I felt like I had laryngitis. I feel like my chronic colitis has started becoming under control. After about two weeks after my vaccine. It has become unmanageable and I can not leave the house due to the urgency. I have had difficulty sleeping and a non productive cough.
2nd pregnancy 09/11/2021EDD, Gestational Diabetes Onset, Ongoing as of 07/22/2021
slight fever; mild soreness at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight fever) and VACCINATION SITE PAIN (mild soreness at the site of the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (slight fever) and VACCINATION SITE PAIN (mild soreness at the site of the injection). At the time of the report, PYREXIA (slight fever) had resolved and VACCINATION SITE PAIN (mild soreness at the site of the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported.
No additional AE; PROQUAD was administered after a temperature excursion; This spontaneous report has been received from a nurse, concerning to a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies.  On an unknown date, the with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) underwent a temperature excursion of -14.1 grades Celsius (C) for a timeframe of 12 minutes (product storage error). There were no previous temperature excursions.  Consequently, on 25-JAN-2022, the patient was vaccinated with the inappropriate storage  Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD)  at a dose of 0.5 milliliters (mL) (lot number U016975 has been verified to be a valid lot number, expiration date reported and established as 24-NOV-2022) as prophylaxis (formulation, strength, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).
Rash onset 24AUG91 on stomach back seen by MD 26AUG91, rash was generalized, was told DTP rxn t100.8; MD advised not to get Pertussis vax;
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via a company representative via webform concerned an elderly female of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on 20-MAR-2021 for covid-19 prophylaxis.  The patient did not experience any adverse event after covid-19 vaccine ad26. cov2. s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on 26-NOV-2021 for covid-19 prophylaxis. Age at time of vaccination 71 years old. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in MAY-2022, the patient experienced covid-19 and had mild symptoms with an annoying cough that lasted a few months (suspected covid-19 infection) (dose number in series 2). The patient enquired if JNJ was offering third shot and said physicians seemed to know nothing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection. This report was non-serious. This report was associated with product quality complaint: 90000246807
After I received my 3rd dose, I had a low-grade fever for about two days. I did develop a chronic cough, accompanied by a low fever and occasional chills, around July of 2022 that I have not been able to get rid of for about 4 months, and along with that I experience a shortness of breath. On September 23 I had a procedure done for my lymph nodes in my lungs and the results showed pulmonary histoplasmosis, which is having a fungal infection in the lung.
This patient received one Johnson and Johnson dose and two Moderna doses. He then received an additional half dose of Moderna today (4//4/22). He was not yet due for an additional dose today. No adverse reactions noted.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age. The patient's medical history and current conditions are not reported. On 30-SEP-2014 the patient was vaccinated with ZOSTAVAX (lot # J007207 and expiry date 20-SEP-2014. It was reported that the patient was inadvertently administered an expired dose of ZOSTAVAX. No adverse events reported. Product quality complaint was not reported. The outcome of the event is unknown. Additional information has been requested.
condition aggravated; attempt to rise from bed difficult and painful; attempts to walk were difficult; severe pain in body joints / in constant knee pain; Malaise; sleepiness; soreness at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GAIT DISTURBANCE (attempts to walk were difficult) and CONDITION AGGRAVATED (condition aggravated) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Spinal stenosis (His Spinal Stenosis is worse.) since 1999, Osteoarthritis (He is scheduled for a right knee replacement on 04 Jun 2021. Both knees will have to be replaced.) since 1999 and Pollen allergy. Concomitant products included METOPROLOL, LISINOPRIL, THEOPHYLLINE, FAMOTIDINE, FINASTERIDE, ROSUVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and MECLIZINE HCL for an unknown indication.   On 10-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 10-Feb-2021, the patient experienced MALAISE (Malaise). 10-Feb-2021, the patient experienced SOMNOLENCE (sleepiness). On 11-Feb-2021, the patient experienced GAIT DISTURBANCE (attempts to walk were difficult) (seriousness criterion disability), MOBILITY DECREASED (attempt to rise from bed difficult and painful) and ARTHRALGIA (severe pain in body joints / in constant knee pain). On an unknown date, the patient experienced CONDITION AGGRAVATED (condition aggravated) (seriousness criterion disability). The patient was treated with OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (attempts to walk were difficult), MOBILITY DECREASED (attempt to rise from bed difficult and painful) and ARTHRALGIA (severe pain in body joints / in constant knee pain) had not resolved and CONDITION AGGRAVATED (condition aggravated), MALAISE (Malaise), SOMNOLENCE (sleepiness) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Developed headache 2 hours later. Swelling & pain at injection site 3 hrs after injection. After 24 hours, swelling extending to elbow, blotchy redness covering upper arm, pain & soreness to touch.
Information has been received from a nurse practitioner, for GARDASIL, a Pregnancy Registry product, concerning a 16 year old female who on 13-DEC-2011 was vaccinated with third dose of GARDASIL (Lot# and dose not reported), intramuscularly. The nurse reported that the patient was determined to be 6 weeks and 3 days pregnant. The date of conception had been calculated to be approximately 13 days after the vaccine was administered. The patient did not seek any medical attention. No treatment was given. There were no adverse events reported. Follow-up information has been received from the nurse practitioner concerning the 16 year old female with a history of acid reflux and there were no previous deliveries who on 13-DEC-2011 was vaccinated with the third dose of GARDASIL. On 26-JAN-2012, the patient experienced depression and she was treated with CELEXA at 20 mg daily. It was reported that on 14-FEB-2012, the patient experienced insomnia and she was treated with BENADRYL one time. On 20-FEB-2012 and 21-FEB-2012, the patient experienced headache and she was treated with TYLENOL 325-450 mg, three times. Concomitant therapy included prenatal vitamins (unspecified) daily since 26-JAN-2012. On 26-JAN-2012, ultrasound was preformed and the patient had been pregnant for 6 weeks and 3 days. The date of estimated conception was 25-DEC-2011 (LMP: 12-DEC-2011, EDD: 17-SEP-2012). Follow-up information has been received. Patient was no longer at the practice and there was no additional information to provided. Pregnancy outcome was updated to lost to follow up. All telephone attempts to obtain follow-up information have been unsuccessful. All scheduled correspondence was canceled.
low grade fevers 8 days and not resolved. Myalgias, arthralgias, profound fatigue, not resolved. Pleuritic substernal chest pain not resolved. Marked increase in various arrhythmias.
Early Miscarriage the week following the second vaccine- following 2 previous positive pregnancy tests; This is a spontaneous report from a contactable consumer (patient). A 31-years-old female pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm right at age of 31 years on 10Jun2021 11:15 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history included diagnosed with COVID-19 Prior to vaccination. The patient's concomitant medications were none, no any other vaccines within 4 weeks prior to the COVID vaccine; no any other medications the patient received within 2 weeks of vaccination. The patient previously took BNT162B2 dose 1 in left arm at age of 31 years on 21May2021 13:00. The patient experienced early miscarriage on 18Jun2021 17:00 the week following the second vaccine- following 2 previous positive pregnancy tests (Seriousness criteria reported as congenital anomaly/birth defect). Last menstrual date was 19May2021 and due to deliver on 22Feb2022. Since the vaccination, patient has not been tested for COVID-19. No treatment was received. The outcome of the event was recovered with sequelae in Jun2021.  Information on the lot/batch number has been requested.
Patient reports that the syringe was not in arm fully, claims it's a sub q shot. Had swelling, bruising , pain , itching at the site . There is a "lump" where the injection was given. Does not report any vaccine leakage at the time of the injection.
3 days after the first Pfizer COVID vaccination, the patient had nausea, vomiting, dizziness, hearing loss and loss of equilibrium. These symptoms slowly resolved, but recurred 3 days after the second dose of the Pfizer COVID vaccine.
Information has been received from a nurse concerning her 15 year old daughter with a history of "zones out" who was vaccinated on an unspecified date with her second dose of GARDASIL (lot# not reported). There was no concomitant medication. In January 2008, the patient experienced twitching of her hands and feet. The patient's twitching of her hands and feet persisted. Additional information has been requested.
Employee had tingling and numbness in arm a few minutes after injection.  This improved within 30 she left the clinic at 40 minutes post vaccine injection.  While driving home employee reports having a sudden onset of headache, palpitations and thick speech.  Her sister with whom she was taking on the phones told her that her  speech sounded strange.  Employee had pulled over and called 911.  EMS spent time with her and her symptoms subsided so they released her to her own care.  She went home and noted nausea, chills then had the onset of a migraine.  She took po Benadryl thinking this would help if she was having an allergic reaction.  Employee reports feeling achy and chilled so missed work on Saturday.  Sunday she was well enough to report to work.  Monday upon checking in with this employee she reports mild soreness at injection site, otherwise no residual symptoms
Synopsis of event from ED and attending physician documentation, and pt. interview by this nurse: ...not feeling well for two days with dyspnea on exertion, fatigue, palpitations and mild body aching. Denies any chest pain, shortness of breath at rest or pleuritic pain, noticed lump over anterior right lower leg. Denies hx of leg swelling, calf or thigh pain, no recent travel by air or car. Received first COVID-19 vaccine 7/15/2021. States Friday, 7/16/2021 had 'pins and needles' sensation anterior lower leg then developed lump in that area, painful to touch, slightly reddened. Hx of torn fascia in area per pt. Denies fever, no nausea, vomiting or diarrhea.
Woke up with a moderate rash up and down on my right arm (injection arm). Rash was itchy and started near the injection site and traveled down to my wrist. Rash remained active for 24 hours but was controlled by Betamethasone Dipropionate that I had on hand for Psoriasis flare-ups. Took 3-4 days to completely go away.
been 2 years since the 1st dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, it had been 2 years since the 1st dose of Shingrix. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, wchich led to incomplete course of vaccination. No reactions reported. The reporter did not consent to follow up.
Patient developed a rash on her upper left arm. She noticed the rash appearing two days post-vaccination. She reported that the rash is itchy and warm to the touch, and her upper arm feels sore. No other adverse effects reported at this time. Recommended the patient take diphenhydramine for help with symptoms.